Virtual Group Resilient Living Program For Patients Living With Advanced Cancer
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Virtual Group Resilient Living Program (RLP), Survey Completion.
- Who it may be relevant to
- Registry conditions: Advanced Cancer. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
This study is a prospective, minimal risk, non-randomized, single-arm study to determine feasibility and assess effectiveness of a Virtual Group Resilient Living Program (RLP) on anxiety, stress, quality of life (QOL), coping, and fatigue among patients with advanced cancer. The group RLP is a psychosocial intervention that consists of a total of 7 weekly sessions in which the interventionalist teaches the patients techniques on stress management and building resilience (mindfulness, uplifting emotions, reframe experiences through principles of gratitude, compassion, acceptance, meaning, and forgiveness). The group setting allows for support and connection amongst the patients, providing further support and motivation to practice the principles of the program.
Interventions
- Behavioral Virtual Group Resilient Living Program (RLP)
The Resilient Living Program (RLP) is a virtual program consisting of online modules and virtual training sessions focused on techniques for managing stress and building resilience (mindful presence, uplifting emotions, and reframing experiences through principles of gratitude, compassion, acceptance, meaning, and forgiveness). - Other Survey Completion
Participants will complete study-related surveys.
Primary outcome measures
- Enrollment Feasibility [Time frame: Up to 1 year]
- Completion Feasibility [Time frame: Up to 1 year]
- Acceptability - Was it Worth it (WIWI) [Time frame: After week 7 session]
Secondary outcome measures (5)
- Change in Anxiety - GAD-7 [Time frame: Baseline, after week 7 session, 30 days after week 7 session]
- Change in Stress - PSS [Time frame: Baseline, after week 7 session, 30 days after week 7 session]
- Change in Quality of Life (QoL) - FACT-G [Time frame: Baseline, after week 7 session, 30 days after week 7 session]
- Change in Coping - Brief COPE [Time frame: Baseline, after week 7 session, 30 days after week 7 session]
- Change in Fatigue - PROMIS-Fatigue [Time frame: Baseline, after week 7 session, 30 days after week 7 session]
Eligibility criteria
Inclusion criteria
- English fluency
- Diagnosis of advanced (stage III/IV) malignancy
- Baseline distress score ≥ 4/10. Patients can answer questions orally rather than complete worksheet, if applicable
- Life expectancy of ≥ 6 months
- Provide informed consent
- Ability to complete questionnaire(s) by themselves or with assistance
- Has a reliable internet connection
- Has the ability to utilize technology to watch online modules, \& participate in virtual sessions
Exclusion criteria
- As determined through self-report, those diagnosed with a history of a psychotic episode ≤ 5 years
- All psychological co-morbidities such as a history of untreated schizophrenia, \& bipolar disease
- A diagnosis of severe cognitive impairment
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Supportive care
Study locations
United States · 1 center
- Mayo Clinic in Rochester — Rochester
Identifiers
NCT: NCT07659158 · MC250905 · 25-011765 · MNCCTN043